Agendia
Ron Kalfus serves as the CFO at Agendia since July 2025, a molecular diagnostic company focused on genomic diagnostics products. Previously, Kalfus held the CFO position at mdxhealth from July 2019 to July 2025, where molecular diagnostic information was provided to personalize cancer treatment. Kalfus's experience includes interim CFO roles at OCTAGON Consulting, and a tenure as CFO at Rosetta Genomics, MabCure, and financial positions at Toys R Us, J.H. Cohn LLP, and Cherry, Bekaert & Holland LLP. Kalfus possesses a BBA in Finance from the University of Georgia and a Master’s in Accounting from Fairleigh Dickinson University.
This person is not in any teams
This person is not in any offices
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.